Central Serotonin Receptors

  • M. Hamon
  • S. Bourgoin
  • S. El Mestikawy
  • C. Goetz


With the catecholamines (dopamine, norepinephrine, and epinephrine), serotonin (5-HT, 5-hydroxytryptamine) is one of the best known biogenic amine neurotransmitters in the CNS. During the past 20 years, an abundant literature has been devoted to this molecule, exploring its distribution, metabolism, and functions. However, investigations on the specific receptors involved in serotoninergic neurotransmission really began only in 1974 with the introduction of binding assays using tritium-labeled ligands with high specific radioactivities. The present review is an attempt to summarize the most important findings reported on central 5-HT receptors, mainly during the last 7 years.


Adenylate Cyclase Adenylate Cyclase Activity Tryptophan Hydroxylase Brain Membrane Apparent Affinity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Azmitia, E. C., 1978, Handbook of Psychopharmacology ,Volume 9 (L. L. Iversen, S. D. Iversen, and S. H. Snyder, eds.), Plenum Press, New York, pp. 233–314.Google Scholar
  2. 2.
    Beaudet, A., and Descarries, L., 1981, J. Physiol. (Paris) 77:193–203.Google Scholar
  3. 3.
    Gershon, M. D., 1981, J. Physiol. (Paris) 77:257–265.Google Scholar
  4. 4.
    Hamon, M., Bourgoin, S., Artaud, F., and El Mestikawy, S., 1981, J. Physiol. (Paris) 77:269–279.Google Scholar
  5. 5.
    Pardridge, W. M., 1979, J. Neural Transm. [Suppl.] 15:43–54.Google Scholar
  6. 6.
    Gessa, G. L., and Tagliamonte, A., 1974, Aromatic Amino Acids in the Brain (G. E. W. Wolstenholme and D. W. Fitzsimons, eds.), Elsevier-North Holland-Excerpta Medica, Amsterdam, pp. 207–216.Google Scholar
  7. 7.
    Herr, B. E., and Roth, R. H., 1976, Brain Res. 110:189–193.PubMedGoogle Scholar
  8. 8.
    Bourgoin, S., Oliveras, J. L., Bruxelle, J., Hamon, M., and Besson, J. M., 1980, Brain Res. 194:377–389.PubMedGoogle Scholar
  9. 9.
    Hamon, M., and Glowinski, J., 1974, Life Sci. 15:1533–1548.PubMedGoogle Scholar
  10. 10.
    Yamauchi, T., Nakata, H., and Fujisawa, H., 1981, J. Biol. Chem. 256:5404–5409.PubMedGoogle Scholar
  11. 11.
    Zivcovic, B., Guidotti, A., and Costa, E., 1974, Adv. Biochem. Psychopharmacol. 11:19–30.Google Scholar
  12. 12.
    El Mestikawy, S., Goetz, C., Pasquier, A., Glowinski, J., and Hamon, M., 1982, Brain Res. 244:319–329.PubMedGoogle Scholar
  13. 13.
    Bourgoin, S., Faivre-Bauman, A., Benda, P., Glowinski, J., and Hamon, M., 1974, J. Neu rochem. 23:319–327.Google Scholar
  14. 14.
    Bennett, J. P., and Snyder, S. H., 1975, Brain Res. 94:523–544.PubMedGoogle Scholar
  15. 15.
    Gaddum, J. H., and Picarelli, Z. P., 1957, Brit. J. Pharmacol. 12:323–328.PubMedGoogle Scholar
  16. 16.
    Wallis, D., 1981, Life Sci. 29:2345–2355.PubMedGoogle Scholar
  17. 17.
    Gerschenfeld, H. M., and Paupardin-Tritsch, D., 1974, J. Physiol. (Lond.) 243:427–457.Google Scholar
  18. 18.
    Rogawski, M. A., and Aghajanian, G. K., 1981, J. Neurosci. 1:1148–1154.PubMedGoogle Scholar
  19. 19.
    Peroutka, S. J., and Snyder, S. H., 1979, Mol. Pharmacol. 16:687–699.PubMedGoogle Scholar
  20. 20.
    Marchbanks, R. M., 1966, J. Neurochem. 13:1481–1493.PubMedGoogle Scholar
  21. 21.
    Alivisatos, S. G. A., Ungar, F., Seth, P. K., Levitt, L. P., Geroulis, A. J., and Meyer, T., 1971, Science 171:809–812.PubMedGoogle Scholar
  22. 22.
    Farrow, J. T., and Van Vunakis, H., 1973, Biochem. Pharmacol. 22:1103–1113.PubMedGoogle Scholar
  23. 23.
    Bennett, J. L., and Aghajanian, G. K., 1974, Life Sci. 15:1934–1944.Google Scholar
  24. 24.
    Nelson, D. L., Herbet, A., Bourgoin, S., Glowinski, J., and Hamon, M., 1978, Mol. Phar macol. 14:983–995.Google Scholar
  25. 25.
    Nelson, D. L., Herbet, A., Pichat, L., Glowinski, J., and Hamon, M., 1979, Naunyn-Schmie deberg’ s Arch. Pharmacol. 310:25–33.Google Scholar
  26. 26.
    Duchemin, A.-M., Quach, T. T., Rose, C., and Schwartz, J. C., 1979, Life Sci. 24:401–410.PubMedGoogle Scholar
  27. 27.
    Clements-Jewery, S., and Robson, P. A., 1980, Neuropharmacology 19:657–661.PubMedGoogle Scholar
  28. 28.
    Von Hungen, K., Roberts, S., and Hill, D. F., 1975, Brain Res. 84:257–267.Google Scholar
  29. 29.
    Enjalbert, A., Bourgoin, S., Hamon, M., Adrien, J., and Bockaert, J., 1978, Mol. Pharmacol. 14:2–10.PubMedGoogle Scholar
  30. 30.
    Fillion, G., Beaudoin, D., Rousselle, J. C., Deniau, J. M., Fillion, M. P., Dray, F., and Jacob, J., 1979, J. Neurochem. 33:567–570.PubMedGoogle Scholar
  31. 31.
    Hamon, M., Nelson, D. L., Herbet, A., and Glowinski, J., 1980, Adv. Biochem. Psycho pharmacol. 21:223–233.Google Scholar
  32. 32.
    Enjalbert, A., Hamon, M., Bourgoin, S., and Bockaert, J., 1978, Mol. Pharmacol. 14:11–23.PubMedGoogle Scholar
  33. 33.
    Segal, M., and Gutnick, M. J., 1980, Brain Res. 195:389–401.PubMedGoogle Scholar
  34. 34.
    Baumann, P. A., and Waldemeier, P. C., 1981, Naunyn-Schmiedeberg`s Arch. Pharmacol. 317:36–43.Google Scholar
  35. 35.
    Fillion, G. M. B., Rousselle, J.-C., Fillion, M.-P., Beaudoin, D. M., Goiny, M. R., Deniau, J.-M., and Jacob, J. J., 1978, Mol. Pharmacol. 14:50–59.PubMedGoogle Scholar
  36. 36.
    Pedigo, N. W., Yamamura, H. I., and Nelson, D. L., 1981, J. Neurochem. 36:220–226.PubMedGoogle Scholar
  37. 37.
    Peroutka, S. J., and Snyder, S. H., 1981, Brain Res. 208:339–347.PubMedGoogle Scholar
  38. 38.
    Heltzel, J. A., Boehme, D. H., and Vogel, W. H., 1981, Brain Res. 204:451–454.PubMedGoogle Scholar
  39. 39.
    Young, W. S. III, and Kuhar, M. J., 1980, Eur. J. Pharmacol. 62:237–239.PubMedGoogle Scholar
  40. 40.
    Bennett, J. P., Jr., and Snyder, S. H., 1976, Mol. Pharmacol. 12:373–389.PubMedGoogle Scholar
  41. 41.
    Hamon, M., Mallat, M., Herbet, A., Nelson, D. L., Audinot, M., Pichat, L., and Glowinski, J., 1981, J. Neurochem. 36:613–626.PubMedGoogle Scholar
  42. 42.
    Fillion, G., Beaudoin, D., Rousselle, J. C., and Jacob, J., 1980, Brain Res. 198:361–374.PubMedGoogle Scholar
  43. 43.
    Leysen, J. E., Niemegeers, C. J. E., Tollenaere, J. P., and Laduron, P. M., 1978, Nature 272:168–171.PubMedGoogle Scholar
  44. 44.
    Creese, I., and Snyder, S. H., 1978, Eur. J. Pharmacol. 49:201–202.PubMedGoogle Scholar
  45. 45.
    Seeman, P., Westman, K., Coscina, D., and Warsh, J. J., 1980, Eur. J. Pharmacol. 66:179–191.PubMedGoogle Scholar
  46. 46.
    Azmitia, E., 1978, Trends Neurosci. August 45–48.Google Scholar
  47. 47.
    Meibach, R. C., Maayani, S., and Green, J. P., 1980, Eur. J. Pharmacol. 67:371–382.PubMedGoogle Scholar
  48. 48.
    Peroutka, S. J., and Snyder, S. H., 1981, J. Pharmacol. Exp. Ther. 216:142–148.PubMedGoogle Scholar
  49. 49.
    Leysen, J. E., Awouters, F., Kennis, L., Laduron, P. M., Vandenberk, J., and Janssen, P. A. J., 1981, Life Sci. 28:1015–1022.PubMedGoogle Scholar
  50. 50.
    Leysen, J. E., Verwimp, M., Geerts, R., Gommeren, W., and Laudron, P. M., 1981, Neurosci. Abstract 6.3, p. 7.Google Scholar
  51. 51.
    Battaglia, G., and Titeler, M., 1981, Life Sci. ,29:909–916.PubMedGoogle Scholar
  52. 52.
    Nelson, D. L., Herbet, A., Enjalbert, A., Bockaert, J., and Hamon, M., 1980, Biochem. Pharmacol. 29:2445–2453.PubMedGoogle Scholar
  53. 53.
    Euvrard, C., and Boissier, J. R., 1980, Eur. J. Pharmacol. 63:65–72.PubMedGoogle Scholar
  54. 54.
    Hamon, M., Nelson, D. L., Herbet, A., Bockaert, J., and Glowinski, J., 1980, Monogr. Neural Sci. 7:161–175.PubMedGoogle Scholar
  55. 55.
    Bourgoin, S., Enjalbert, A., Adrien, J., Héry, F., and Hamon, M., 1977, Brain Res. 127:111–126.PubMedGoogle Scholar
  56. 56.
    Nelson, D. L., Herbet, A., Adrien, J., Bockaert, J., and Hamon, M., 1980, Biochem. Phar macol. 29:2455–2463.Google Scholar
  57. 57.
    Fillion, G., Rousselle, J. C., Beaudoin, D., Pradelles, P., Goiny, M., Dray, F., and Jacob, J., 1979, Life Sci. 24:1813–1822.PubMedGoogle Scholar
  58. 58.
    Daszuta, A., Pons, F., and Cadilhac, J., 1979, Eur. J. Pharmacol. 56:397–401.PubMedGoogle Scholar
  59. 59.
    Ahn, H. S., and Makman, M. H., 1978, Brain Res. 153:636–640.PubMedGoogle Scholar
  60. 60.
    Tsang, D., and Lai, S., 1977, Can. J. Physiol. Pharmacol. 55:1263–1269.PubMedGoogle Scholar
  61. 61.
    Poller, D., Carroll, J. A., and Middlemiss, D. N., 1981, Eur. J. Pharmacol. 72:121–123.PubMedGoogle Scholar
  62. 62.
    Shih, J. C., and Cheng, S. H., 1981, Adv. Exp. Med. Biol. 133:319–325.PubMedGoogle Scholar
  63. 63.
    Ilien, B., Gorissen, H., and Laduron, P., 1980, Biochem. Pharmacol. 29:3341–3344.PubMedGoogle Scholar
  64. 64.
    Chan, B., Seeman, P., Dumbrille-Ross, A., and Madras, B. K., 1981, Neurosci. Abstract 6.4, p. 7.Google Scholar
  65. 65.
    Mallat, M., and Hamon, M., 1982, J. Neurochem. 38:151–161.PubMedGoogle Scholar
  66. 66.
    Peroutka, S. J., Lebovitz, R. M., and Snyder, S. H., 1979, Mol. Pharmacol. 16:700–708.PubMedGoogle Scholar
  67. 67.
    Hamon, M., Bourgoin, S., Enjalbert, A., Bockaert, J., Héry, F., Ternaux, J. P., and Glowinski, J., 1976, Naunyn-Schmiedeberg’s Arch. Pharmacol. 294:99–108.Google Scholar
  68. 68.
    Middlemiss, D. N., Carroll, J. A., Fisher, R. W., andMounsey, I. J., 1980, Eur. J. Pharmacol. 66:253–254.PubMedGoogle Scholar
  69. 69.
    Marchais, D., and Bockaert, J., 1980, Biochem. Pharmacol. 29:1331–1336.PubMedGoogle Scholar
  70. 70.
    Rosenfeld, M. R., and Makman, M. H., 1981, J. Pharmacol. Exp. Ther. 216:526–531.PubMedGoogle Scholar
  71. 71.
    Rodbell, M., 1980, Nature 284:17–22.PubMedGoogle Scholar
  72. 72.
    Fong, H. M. C., Okada, K., and Goldstein, M., 1982, Eur. J. Pharmacol. 77:57–59.PubMedGoogle Scholar
  73. 73.
    Hamon, M., Mallat, M., El Mestikawy, S., and Pasquier, A., 1982, J. Neurochem. 38:162–172.PubMedGoogle Scholar
  74. 74.
    Schleifer, L. S., Garrison, J. C., Sternweis, P. C., Northup, J. K., and Gilman, A. G., 1980, J. Biol. Chem. 225:2641–2644.Google Scholar
  75. 75.
    Heron, D. S., Shinitzky, M., Hershkowitz, M., and Samuel, D., 1980, Proc. Natl. Acad. Sci. U.S.A. 77:7463–7467.PubMedGoogle Scholar
  76. 76.
    Hanski, E., Rimon, G., and Levitzki, A., 1979, Biochemistry 18:846–853.PubMedGoogle Scholar
  77. 77.
    Biegon, A., and Samuel, D., 1980, Neurotransmitters and Their Receptors (U. Z. Littauer, Y. Dudai, I. Silman, V. I. Teichberg, and Z. Vogel, eds.), John Wiley & Sons, New York, Chichester, pp. 119–124.Google Scholar
  78. 78.
    Fillion, G., and Fillion, M. P., 1981, Nature 292:349–351.PubMedGoogle Scholar
  79. 79.
    Segawa, T., Mizuta, T., and Nomura, Y., 1979, Eur. J. Pharmacol. 58:75–83.PubMedGoogle Scholar
  80. 80.
    Savage, D. D., Mendels, J., and Frazer, A., 1980, Neuropharmacol. 19:1063–1070.Google Scholar
  81. 81.
    Whitaker, P. M., and Deakin, J. F. W., 1981, Eur. J. Pharmacol. 73:349–351.Google Scholar
  82. 82.
    Blackburn, T. P., Cox, B., Heapy, C. G., Lee, T. F., and Middlemiss, D. N., 1981, Eur. J. Pharmacol. 71:343–346.PubMedGoogle Scholar
  83. 83.
    Trulson, M. E., Eubanks, E. E., and Jacobs, B. L., 1976, J. Pharmacol. Exp. Ther. 198:23–32.PubMedGoogle Scholar
  84. 84.
    Ferron, A., Descarries, L., and Reader, T. A., 1982, Brain Res. 231:93–108.PubMedGoogle Scholar
  85. 85.
    De Montigny, C., Wang, R. Y., Reader, T. A. and Aghajanian, G. K., 1980, Brain Res. 200:363–376.PubMedGoogle Scholar
  86. 86.
    Segal, M., 1981, Adv. Exp. Med. Biol. 133:375–390.PubMedGoogle Scholar
  87. 87.
    Blackshear, M. A., Steranka, L. R., and Sanders-Bush, E., 1981, Eur. J. Pharmacol. 76:325–334.PubMedGoogle Scholar
  88. 88.
    Fleisher, L. N., Simon, J. R., and Aprison, M. H., 1979, J. Neurochem. 32:1613–1619.PubMedGoogle Scholar
  89. 89.
    Steigrad, P., Tobler, I., Waser, P. G., and Borbély, A. A., 1978, Naunyn-Schmiedeberg’s Arch. Pharmacol. 305:143–148.Google Scholar
  90. 90.
    Samanin, R., Mennini, T., Ferraris, A., Bendotti, C., and Borsini, F., 1980, Brain Res. 189:449–457.PubMedGoogle Scholar
  91. 91.
    Wirz-Justice, A., Krauchi, K., Lichsteiner, M., and Feer, H., 1978, Life Sci. 23:1249–1254.PubMedGoogle Scholar
  92. 92.
    Maggi, A., U’Pritchard, D. C., and Enna, S. J., 1980, Eur. J. Pharmacol. 61:91–98.PubMedGoogle Scholar
  93. 93.
    Savage, D. D., Frazer, A., and Mendels, J., 1979, Eur. J. Pharmacol. 58:87–88.PubMedGoogle Scholar
  94. 94.
    Savage, D. D., Mendels, J., and Frazer, A., 1980, J. Pharmacol. Exp. Ther. 212:259–263.PubMedGoogle Scholar
  95. 95.
    Tang, S. W., Seeman, P., and Kwan, S., 1981, Psychiatr. Res. 4:129–138.Google Scholar
  96. 96.
    Peroutka, S. J., and Snyder, S. H., 1980, Science 210:88–90.PubMedGoogle Scholar
  97. 97.
    Fuxe, K., Ögren, S.-O., and Agnati, L. F., 1979, Neurosci. Lett. 13:307–312.PubMedGoogle Scholar
  98. 98.
    Fuxe, K., Ögren, S.-O., Agnati, L. F., Eneroth, P., Holm, A. C., and Andersson, K., 1981, Neurosci. Lett. 21:57–62.PubMedGoogle Scholar
  99. 99.
    Bergstrom, D. A., and Kellar, K. J., 1979, J. Pharmacol. Exp. Ther. 209:256–261.PubMedGoogle Scholar
  100. 100.
    Kellar, K. J., Cascio, C. S., Butler, J. A., and Kurtzke, R. N., 1981, Eur. J. Pharmacol. 69:515–518.PubMedGoogle Scholar
  101. 101.
    Peroutka, S. J., and Snyder, S. H., 1980, J. Pharmacol. Exp. Ther. 215:582–587.PubMedGoogle Scholar
  102. 102.
    Kendall, D. A., Stancel, G. M., and Enna, S. J., 1981, Science 211:1183–1185.PubMedGoogle Scholar
  103. 103.
    Taylor, D. P., Allen, L. E., Ashworth, E. M., Becker, J. A., Hyslop, D. K., and Riblet, L. A., 1981, Neuropharmacology 20:513–516.PubMedGoogle Scholar
  104. 104.
    Peroutka, S. J., Lebovitz, R. M., and Snyder, S. H., 1981, Science 212:827–829.PubMedGoogle Scholar
  105. 105.
    Dumbrille-Ross, A., Tang, S. W., and Coscina, D. V., 1981, Life Sci. 29:2049–2058.PubMedGoogle Scholar
  106. 106.
    Olpe, H.-R., 1981, Eur. J. Pharmacol. 69:375–377.PubMedGoogle Scholar
  107. 107.
    De Montigny, C., and Aghajanian, G. K., 1978, Science 202:1303–1306.PubMedGoogle Scholar
  108. 108.
    Friedman, E., and Dallob, A., 1979, Commun. Psychopharmacol. 3:89–92.PubMedGoogle Scholar
  109. 109.
    Buxton, D. A., Marsden, C. A., and Stolz, J. F., 1981, Br. J. Pharmacol. 74:215p.Google Scholar
  110. 110.
    Jones, R. S. G., 1980, Psychopharmacology 69:307–311.PubMedGoogle Scholar
  111. 111.
    Mennini, T., Poggesi, E., Caccia, S., Bendotti, C., Borsini, F., and Samanin, R., 1980, Neurotransmitters and their Receptors (U. Z. Littauer, Y. Dudai, I. Silman, V. I. Teichberg, and Z. Vogel, eds.), John Wiley & Sons, New York, Chichester, pp. 101–118.Google Scholar
  112. 112.
    Trulson, M. E., and Jacobs, B. L., 1979, Life Sci. 24:2053–2062.PubMedGoogle Scholar
  113. 113.
    Muller, P., and Seeman, P., 1977, Life Sci. 21:1751–1758.PubMedGoogle Scholar
  114. 114.
    Dawbarn, D., Long, S. K., and Pycock, C. J., 1981, Br. J. Pharmacol. 73:149–156.PubMedGoogle Scholar
  115. 115.
    Vetulani, J., Lebrecht, U., and Pilc, A., 1981, Eur. J. Pharmacol. 76:81–85.PubMedGoogle Scholar
  116. 116.
    Muller, P., Britton, R. S., and Seeman, P., 1980, Eur. J. Pharmacol. 65:31–37.PubMedGoogle Scholar
  117. 117.
    Treiser, S. L., Cascio, C. S., O’Donohue, T. L., Thoa, N. B., Jacobowitz, D. M., and Kellar, K. J., 1981, Science 213:1529–1531.PubMedGoogle Scholar
  118. 118.
    Samanin, R., Cervo, L., Rochat, C., Poggesi, E., and Mennini, T., 1980, Life Sci. 27:1141–1146.PubMedGoogle Scholar
  119. 119.
    Green, A. R., Heal, D. J., and Grahame-Smith, D. G., 1977, Psychopharmacology 52:195–200.PubMedGoogle Scholar
  120. 120.
    Hamon, M., Nelson, D. L., Mallat, M., and Bourgoin, S., 1981, Neurochem. Int. 3:69–79.PubMedGoogle Scholar
  121. 121.
    Chanez, C., Priam, M., Flexor, M.-A., Hamon, M., Bourgoin, S., Kordon, C., and Minkowski, A., 1981, Brain Res. 207:397–408.PubMedGoogle Scholar
  122. 122.
    Young, A. B., Zukin, S. R., and Snyder, S. H., 1974, Proc. Natl. Acad. Sci. U.S.A. 71:2246–2250.PubMedGoogle Scholar
  123. 123.
    Dray, A., and Straughan, D. W., 1976, J. Pharm. Pharmacol. 28:314–315.PubMedGoogle Scholar
  124. 124.
    Dolphin, A. C., and Greengard, P., 1981, J. Neurosci. 1:192–203.PubMedGoogle Scholar
  125. 125.
    Kandel, E. R., 1981, Nature 293:697–700.PubMedGoogle Scholar
  126. 126.
    Ennis, C., Kemp, J. D., and Cox, B., 1981, J. Neurochem. 36:1515–1520.PubMedGoogle Scholar
  127. 127.
    Enna, S. J., 1981, Serotonin-Current Aspects of Neurochemistry and Function (B. Haber, S. Gabay, M. R. Issidorides, and S. G. A. Alivisatos, eds.), Plenum Press, New York, pp. 347–357.Google Scholar
  128. 128.
    Drummond, A. H., Benson, J. A., and Levitan, I. B., 1980, Proc. NatL Acad. Sci. U.S.A. 77:5013–5017.PubMedGoogle Scholar
  129. 129.
    Wu, P. H., and Phillis, J. W., 1979, J. Pharm. Pharmacol. 31:782–784.PubMedGoogle Scholar
  130. 130.
    Maura, G., Gemignani, A., Versace, P., Martire, M., and Raiteri, M., 1982, Neurochem. Int. 4:219–224.PubMedGoogle Scholar
  131. 131.
    Göthert, M., and Weinheimer, G., 1979, Naunyn-Schmiedeberg’s Arch. Pharmacol. 310:93–96.Google Scholar
  132. 132.
    Mitchell, R., and Fleetwood-Walker, S., 1981, Eur. J. Pharmacol. 76:119–120.PubMedGoogle Scholar
  133. 133.
    Mounsey, I., Brady, K. A., Carroll, J., Fisher, R., and Middlemiss, D. N., 1982, Biochem. Pharmacol. 31:49–53.PubMedGoogle Scholar
  134. 134.
    Bourgoin, S., Artaud, F., Enjalbert, A., Héry, F., Glowinski, J., and Hamon, M., 1977, J. Pharmacol. Exp. Ther. 202:519–531.PubMedGoogle Scholar
  135. 135.
    Cerrito, F., and Raiteri, M., 1979, Eur. J. Pharmacol. 57:427–430.PubMedGoogle Scholar
  136. 136.
    Hirata, F., and Axelrod, J., 1980, Science 209:1082–1090.PubMedGoogle Scholar
  137. 137.
    Berridge, M. J., and Heslop, J. P., 1981, Br. J. Pharmacol. 73:729–738.PubMedGoogle Scholar
  138. 138.
    Bourgoin, S., Soubrié, P., Artaud, F., Reisine, T. D., and Glowinski, J., 1981, J. Physiol. (Paris) 77:303–307.Google Scholar

Copyright information

© Springer Science+Business Media New York 1984

Authors and Affiliations

  • M. Hamon
    • 1
  • S. Bourgoin
    • 1
  • S. El Mestikawy
    • 1
  • C. Goetz
    • 1
  1. 1.114, Collège de FranceGroupe NB, INSERM UParis, Cedex 05France

Personalised recommendations